Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Prothena Corp Public (PRTA) over the last 14 years, with Q3 2025 value amounting to $10000.0.

  • Prothena Corp Public's Capital Expenditures rose 1111.11% to $10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $181000.0, marking a year-over-year decrease of 8996.67%. This contributed to the annual value of $298000.0 for FY2024, which is 8939.5% down from last year.
  • Latest data reveals that Prothena Corp Public reported Capital Expenditures of $10000.0 as of Q3 2025, which was up 1111.11% from $86000.0 recorded in Q2 2025.
  • In the past 5 years, Prothena Corp Public's Capital Expenditures ranged from a high of $1.5 million in Q4 2023 and a low of $9000.0 during Q3 2024
  • For the 5-year period, Prothena Corp Public's Capital Expenditures averaged around $238055.6, with its median value being $116500.0 (2022).
  • Per our database at Business Quant, Prothena Corp Public's Capital Expenditures skyrocketed by 92582.78% in 2023 and then tumbled by 9796.38% in 2024.
  • Over the past 5 years, Prothena Corp Public's Capital Expenditures (Quarter) stood at $319000.0 in 2021, then tumbled by 52.66% to $151000.0 in 2022, then skyrocketed by 925.83% to $1.5 million in 2023, then tumbled by 97.22% to $43000.0 in 2024, then plummeted by 76.74% to $10000.0 in 2025.
  • Its Capital Expenditures was $10000.0 in Q3 2025, compared to $86000.0 in Q2 2025 and $42000.0 in Q1 2025.